September 23, 2014 5:58 AM ET

Capital Markets

Company Overview of Flagship Ventures

Company Overview

Flagship Ventures is a venture capital firm specializing in incubation, seed stage, early, later and growth stage investments. The firm prefers to invest in the healthcare including biotherapeutics, medical technologies, biological discoveries leading to new therapies, advanced analysis for improved medicine, chemistries and small molecule drugs, nanotechnology for medicine; energy efficiency; bioenergy; sustainability; and cleantechnology sector. The firm seeks to invest in Midwest. It seeks to initially invest between $500,000 and $5 million, with a typical investment between $7 million and $15 million as part of a syndicate in its portfolio companies. The firm typically makes an initial i...

One Memorial Drive

7th Floor

Cambridge, MA 02142

United States

Founded in 2000





Key Executives for Flagship Ventures

Age: 51
Age: 57
Chief Financial Officer
Age: 43
Chief Operating Officer and General Partner
Age: 59
Partner and Chief Business Officer
Age: 60
Compensation as of Fiscal Year 2014.

Flagship Ventures Key Developments

Flagship Ventures Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 through Sep-24-2014

Flagship Ventures Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 through Sep-24-2014. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Presentation Date & Speakers: Sep-22-2014, David A. Berry, Partner.

Flagship Ventures Names Robert Berendes as Venture Partner

Flagship Ventures announced the appointment of Dr. Robert Berendes as its venture partner. Through the company's board and advisory roles, Dr. Berendes will engage with portfolio companies focused on innovations that address sustainability in the energy, water, and agriculture/nutrition sectors, providing strategic counsel and support. Currently, Dr. Berendes is co-owner and partner at a-connect, a consulting firm and talent pool headquartered in Switzerland. Most recently, Dr. Berendes was a member of Syngenta's executive team, head of business development, diverse field crops unit as strategy, planning and M&A department.

Flagship Ventures Presents at World Congress on Industrial Biotechnology, May-12-2014

Flagship Ventures Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

Similar Private Companies By Industry

Company Name Region
Milestone Management Ltd. L.L.C. United States
Blackstone Capital Group, Inc. United States
Gleacher & Co. United States
Pendrith Acquisition, Inc. United States
Montgomery, Marshall Healthcare Partners, LLC United States

Recent Private Companies Transactions

Private Placement
August 26, 2014
Black Duck Software, Inc.
Private Placement
July 28, 2014
Seventh Sense Biosystems, Inc.
Private Placement
May 23, 2014
Seres Health, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Flagship Ventures, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at